Found: 1
Select item for more details and to access through your institution.
Deferiprone (GPO-L-ONE<sup>®</sup>) monotherapy reduces iron overload in transfusion-dependent thalassemias: 1-year results from a multicenter prospective, single arm, open label, dose escalating phase III pediatric study (GPO-L-ONE; A001) from Thailand
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 4, p. 251, doi. 10.1002/ajh.23386
- By:
- Publication type:
- Article